Published

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Biomolecules
Date: 2026-07-03
Source: Crossref
DOI: 10.3390/biom16070983
PubMed: 42509777

Authors

Enriquez-Geppert Stefanie Bevers Lisa Rosander Arvid Fodran Peter Polito Vince

Watch author

Derived topics and classifications

psilocybin Review Article Animal Study Safety Review Article

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.psychres.2023.115531 10.1016/j.neubiorev.2025.106163 10.1016/bs.irn.2025.03.001 10.1016/j.ajp.2024.104242 10.1057/s41292-025-00369-y 10.1556/2054.2025.00432 10.1556/2054.2023.00297 10.3389/fpsyt.2024.1169686 10.1615/intjmedmushr.v10.i3.20 10.1016/j.funbio.2022.01.003 10.1038/s41429-020-0311-8 10.4103/indianjpsychiatry.indianjpsychiatry_707_23

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03

Related papers

No close related records were found yet.